Last10K.com

Actinium Pharmaceuticals, Inc. (ATNM) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020

Actinium Pharmaceuticals, Inc.

CIK: 1388320 Ticker: ATNM
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2020
Mar. 31, 2021
Jun. 30, 2020
Document Information Line Items   
Entity Registrant NameActinium Pharmaceuticals, Inc.  
Document Type10-K  
Current Fiscal Year End Date--12-31  
Entity Common Stock, Shares Outstanding 19,245,638 
Entity Public Float  $ 138,896,884
Amendment Flagfalse  
Entity Central Index Key0001388320  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Filer CategoryNon-accelerated Filer  
Entity Well-known Seasoned IssuerNo  
Document Period End DateDec. 31, 2020  
Document Fiscal Year Focus2020  
Document Fiscal Period FocusFY  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity File Number000-52446  
Entity Incorporation, State or Country CodeDE  
Entity Interactive Data CurrentYes  

View differences made from one year to another to evaluate Actinium Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actinium Pharmaceuticals, Inc..

Continue

Assess how Actinium Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actinium Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Other
Filter Subcategory:
All
Expense
Shares
Cash Flow
Other
Inside Actinium Pharmaceuticals, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statement Of Changes In Stockholders??? Equity
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Accounting Policies, By Policy (Policies)
Commitments And Contingencies
Commitments And Contingencies (Details)
Description Of Business And Summary Of Significant Accounting Policies
Description Of Business And Summary Of Significant Accounting Policies (Details) - Schedule Of Antidilutive Securities Excluded From Computation Of Diluted Net Loss Per Share
Description Of Business And Summary Of Significant Accounting Policies (Details) - Schedule Of Cash And Cash Equivalent And Restricted Cash
Description Of Business And Summary Of Significant Accounting Policies (Tables)
Equity
Equity (Details)
Equity (Details) - Schedule Of Pre-Funded Warrant Activity
Equity (Details) - Schedule Of Stock Option Activity
Equity (Details) - Schedule Of Warrant Activities
Equity (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Details) - Schedule Of Deferred Tax Assets And Liabilities
Income Taxes (Details) - Schedule Of Difference Between Income Tax Provision And U.S Federal Statutory Rates
Income Taxes (Tables)
Leases
Leases (Details) - Schedule Of Components Of Lease Expense
Leases (Details) - Schedule Of Maturities Of Lease Liabilities
Leases (Details) - Schedule Of Supplemental Cash Flow Information Related To Leases
Leases (Details) - Schedule Of Weighted Average Discount Rates
Leases (Details) - Schedule Of Weighted Average Remaining Lease Terms
Leases (Tables)
Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (Details) - Schedule Of Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (Tables)
Property And Equipment
Property And Equipment (Details) - Schedule Of Depreciation Expense
Property And Equipment (Details) - Schedule Of Property And Equipment
Property And Equipment (Tables)
Subsequent Events
Subsequent Events (Details)

Material Contracts, Statements, Certifications & more

Actinium Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ATNM
CIK: 1388320
Form Type: 10-K Annual Report
Accession Number: 0001213900-21-019297
Submitted to the SEC: Wed Mar 31 2021 5:00:34 PM EST
Accepted by the SEC: Wed Mar 31 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/atnm/0001213900-21-019297.htm